Distinguishing between irritated seborrheic keratosis and squamous cell carcinoma in situ using BCL-2 and IMP3 immunohistochemistry.

Justin D RicheyApril C DengKaren DresserPatrick O'DonnellKristine M Cornejo

Published in: Journal of cutaneous pathology (2018)

Our findings indicate that the combination of IMP3 and BCL-2 may be of diagnostic utility in distinguishing between ISK and SCCIS in daily clinical practice. EGFR immunohistochemistry did not appear to be useful in this setting.

Keyphrases

squamous cell
clinical practice
small cell lung cancer
epidermal growth factor receptor
tyrosine kinase
physical activity